Dave Zhang, PhD

2006 Hertz Fellow
Visit website | Find me on LinkedIn

David Zhang is Co-founder and CEO of Biostate AI, a startup with the mission of developing generative AI that can benefit all of human health.

Zhang is a scientist turned entrepreneur focusing on breakthrough product development at the intersection of generative AI and multiomics. He was formerly the Ted Law Jr. Professor of Bioengineering at Rice University, co-founder of Nuprobe Global and Torus Biosystems. Zhang is an inventor on 40+ patent and has co-authored 50+ peer-reviewed publications.

Zhang received his Hertz Fellowship in 2006, and with its support pursued his PhD in computation and neural systems at the California Institute of Technology. His thesis, “Dynamic DNA Strand Displacement Circuits”, recapitulated his 10 graduate publications in the field of DNA nanotechnology. As a postdoc, Dave was a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation, and worked at the Wyss Institute for Biologically Inspired Engineering at the Harvard Medical School.

In his spare time, Dave enjoys reading nonfiction (particularly economics and game theory), and playing board games.

Graduate Studies

California Institute of Technology
Bioengineering
Dynamic DNA Strand Displacement Circuits

Undergraduate Studies

California Institute of Technology

Awards

2019, Department of Health and Human Services, Presidential Early Career Award for Scientists and Engineers

Related News

Sep 26, 2024
David Zhang, formerly of Rice University and NuProbe, is offering affordable RNA sequencing to researchers, repositories and companies, while using the collected data to power biological AI models
May 31, 2016
Hertz Fellow David Zhang, a bioengineer at Rice University, wants to increase the odds of locating those elusive genetic variants that cause disease, and do so in a cost-effective manner. With two separate grants from the National Institutes of Health totaling $5.5 million, Zhang will devote the next five years to efficiently detection and profiling of rare DNA mutations that lead to illness.